Detalhe da pesquisa
1.
Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research.
Cancer
; 129(21): 3430-3438, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382235
2.
Health-related quality of life in adolescents and young adults with cancer who received radiation therapy: a scoping review.
Support Care Cancer
; 31(4): 230, 2023 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961516
3.
Food and Drug Administration approvals in phase 3 Cancer clinical trials.
BMC Cancer
; 21(1): 695, 2021 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118915
4.
Professional Medical Writer Assistance in Oncology Clinical Trials.
Oncologist
; 25(11): e1812-e1815, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885898
5.
Performance Status Restriction in Phase III Cancer Clinical Trials.
J Natl Compr Canc Netw
; 18(10): 1322-1326, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022640
6.
Microbiome factors in HPV-driven carcinogenesis and cancers.
PLoS Pathog
; 16(6): e1008524, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32497113
7.
Sponsor-involved statistical analyses in Phase III cancer clinical trials.
Int J Cancer
; 147(12): 3579-3581, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32621758
8.
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020.
JAMA Netw Open
; 7(3): e243379, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546648
9.
Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network.
Pract Radiat Oncol
; 14(3): e173-e179, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38176466
10.
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials.
J Natl Cancer Inst
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331394
11.
Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions.
Semin Radiat Oncol
; 33(4): 367-373, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37684066
12.
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials.
JAMA Netw Open
; 6(5): e2313819, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195664
13.
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy.
Eur J Cancer
; 194: 113357, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827064
14.
HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development.
Front Immunol
; 14: 1051431, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37063829
15.
Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades.
BMJ Support Palliat Care
; 12(1): 42-45, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32943466
16.
Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials.
Cancers (Basel)
; 14(4)2022 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35205795
17.
Inclusion of premenopausal women in breast cancer clinical trials.
Breast
; 66: 204-207, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327626
18.
The radiotherapy quality assurance gap among phase III cancer clinical trials.
Radiother Oncol
; 166: 51-57, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838891
19.
Microbiome Dynamics During Chemoradiation Therapy for Anal Cancer.
Int J Radiat Oncol Biol Phys
; 113(5): 974-984, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513187
20.
Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers.
Cancer Immunol Res
; 10(2): 259-271, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045973